Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
TDOC Teladoc Health
27.090
+1.190+4.59%
Post Mkt Price
26.950
-0.140-0.52%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Total revenue
17.20% 611.4M 17.74% 592.38M 24.62% 565.35M 85.81% 2.03B
Operating revenue
17.20% 611.4M 17.74% 592.38M 24.62% 565.35M 85.81% 2.03B
Cost of revenue
9.81% 185.62M 13.85% 182.47M 28.14% 187.03M 66.38% 650.26M
Gross profit
20.75% 425.78M 19.55% 409.91M 22.95% 378.33M 96.61% 1.38B
Operating expense
21.30% 495.92M 15.39% 473.57M 14.80% 443.2M 44.60% 1.62B
Selling and administrative expenses
25.08% 346.1M 19.79% 333.37M 14.44% 296.85M 24.63% 1.11B
-Selling and marketing expense
34.47% 233.55M 33.17% 222.5M 24.44% 191.93M 75.52% 667.31M
-General and administrative expense
9.25% 112.54M -0.31% 110.87M -0.24% 104.92M -13.55% 438.01M
Research and development costs
9.43% 87.82M 0.08% 80.83M 12.06% 87.41M 89.09% 311.88M
Depreciation amortization depletion
19.46% 62.01M 15.64% 59.37M 21.11% 58.93M 193.89% 204.24M
-Depreciation and amortization
19.46% 62.01M 15.64% 59.37M 21.11% 58.93M 193.89% 204.24M
Operating profit
-24.72% -70.14M 5.73% -63.66M 17.21% -64.87M 42.85% -238.99M
Net non-operating interest income expense
92.88% -1.35M 78.82% -4.34M 75.23% -5.48M -32.85% -80.37M
Non-operating interest expense
-92.88% 1.35M -78.82% 4.34M -75.23% 5.48M 32.85% 80.37M
Other net income (expense)
43.14% -3.17M -7,019.75% -3.03B -54,341.74% -6.6B 32.89% -65.3M
Special income (charges)
69.29% -1.59M -6,979.58% -3.03B -37,041.53% -6.6B 27.67% -70.39M
-Less:Restructuring and merger&acquisition
-63.27% 1.59M -74.68% 2.89M -28.72% 4.51M -69.80% 26.64M
-Less:Impairment of capital assets
-- 0 -- 3.03B -- 6.6B -- --
-Less:Other special charges
-- -- -- -- -- -- 381.97% 43.75M
Other non- operating income (expenses)
-317.82% -1.57M -911.06% -1.76M -87.19% 724K -- 5.09M
Income before tax
7.50% -74.65M -2,275.27% -3.1B -5,826.77% -6.67B 33.22% -384.66M
Income tax
-132.14% -1.17M -137.17% -1.19M -99.55% 388K 148.58% 44.14M
Net income
12.88% -73.48M -2,217.65% -3.1B -3,243.13% -6.67B 11.61% -428.79M
Net income continuous Operations
12.88% -73.48M -2,217.65% -3.1B -3,243.13% -6.67B 11.61% -428.79M
Minority interest income
Net income attributable to the parent company
12.88% -73.48M -2,217.65% -3.1B -3,243.13% -6.67B 11.61% -428.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
12.88% -73.48M -2,217.65% -3.1B -3,243.13% -6.67B 11.61% -428.79M
Basic earnings per share
15.09% -0.45 -2,134.88% -19.22 -3,074.05% -41.58 49.07% -2.73
Diluted earnings per share
15.09% -0.45 -2,134.88% -19.22 -3,074.05% -41.58 49.07% -2.73
Dividend per share
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.
CEO: Mr. Jason N. Gorevic
Market: NYSE
Listing Date: 07/01/2015
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist